Cookie Consent by FreePrivacyPolicy.com
Datalog Logo
Free data on 57M+ companies
Home > England & Wales Companies > GLIDE PHARMACEUTICAL TECHNOLOGIES LIMITED
Company Information for

GLIDE PHARMACEUTICAL TECHNOLOGIES LIMITED

RSM RESTRUCTURING ADVISORY LLP, 3 HARDMAN STREET, MANCHESTER, M3 3HF,
Company Registration Number
04173789
Private Limited Company
In Administration
Administrative Receiver

Company Overview

About Glide Pharmaceutical Technologies Ltd
GLIDE PHARMACEUTICAL TECHNOLOGIES LIMITED was founded on 2001-03-06 and has its registered office in Manchester. The organisation's status is listed as "In Administration
Administrative Receiver". Glide Pharmaceutical Technologies Limited is a Private Limited Company registered in with Companies House and the accounts submission requirement is categorised as FULL
  • Annual turnover is £6.5 million or more
  • The balance sheet total is £ 3.26 million or more
  • Employs 50 or more employees
  • May be publically listed
  • May be a member of a group of companies meeting any of the above criteria
Key Data
Company Name
GLIDE PHARMACEUTICAL TECHNOLOGIES LIMITED
 
Legal Registered Office
RSM RESTRUCTURING ADVISORY LLP
3 HARDMAN STREET
MANCHESTER
M3 3HF
Other companies in OX14
 
Previous Names
CARETEK MEDICAL LIMITED07/09/2006
MC182 LIMITED23/08/2001
Filing Information
Company Number 04173789
Company ID Number 04173789
Date formed 2001-03-06
Country 
Origin Country United Kingdom
Type Private Limited Company
CompanyStatus In Administration
Administrative Receiver
Lastest accounts 30/06/2016
Account next due 31/03/2018
Latest return 14/01/2016
Return next due 11/02/2017
Type of accounts FULL
VAT Number /Sales tax ID GB784988152  
Last Datalog update: 2018-09-07 01:18:21
Primary Source:Companies House
There are multiple companies registered at this address, the registered address may be the accountant's offices for GLIDE PHARMACEUTICAL TECHNOLOGIES LIMITED
Is this data useful to you?
If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. Please DONATE to help.
Alternatively by linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us.

Company Officers of GLIDE PHARMACEUTICAL TECHNOLOGIES LIMITED

Current Directors
Officer Role Date Appointed
RICHARD EDWARD BUNGAY
Director 2014-07-01
JAMES ANTHONY OTTER
Director 2017-04-27
FRASER ANDREW SKIRROW
Director 2017-02-11
IAN JOSEPH SMITH
Director 2011-12-14
Previous Officers
Officer Role Date Appointed Date Resigned
MEDINNOVATE LTD
Director 2013-05-03 2017-02-11
BRYAN GEOFFREY MORTON
Director 2013-10-25 2017-02-11
MARK CARNEGIE-BROWN
Director 2013-02-22 2016-11-25
MARK RICHARD KIRBY
Director 2005-03-21 2013-10-25
CHARLES DAVID OGILVY POTTER
Director 2001-08-21 2013-10-25
FRASER ANDREW SKIRROW
Director 2005-06-22 2013-05-03
JAMES ANTHONY OTTER
Director 2011-04-13 2013-03-10
VANESSA JANE YOUNG
Company Secretary 2011-04-13 2012-12-14
SIMON JONES
Company Secretary 2005-03-07 2011-04-10
RUSSELL SMITH
Director 2005-03-07 2010-10-19
SIMON JONES
Director 2005-03-07 2010-09-15
CHARLES STUART WEBB SWINGLAND
Director 2006-04-19 2010-09-15
MARGARET ANNE POTTER
Company Secretary 2001-08-21 2005-03-07
MARGARET ANNE POTTER
Director 2001-08-21 2005-03-07
SWIFT INCORPORATIONS LIMITED
Nominated Secretary 2001-03-06 2001-08-21
INSTANT COMPANIES LIMITED
Nominated Director 2001-03-06 2001-08-21

Related Directorships

Officer Related Company Role Date Appointed Role StatusIncorporation dateCompany Status
JAMES ANTHONY OTTER ELLIPSON LIMITED Director 2003-09-04 CURRENT 2003-09-04 Active
FRASER ANDREW SKIRROW MEDINNOVATE LTD Director 2004-12-21 CURRENT 2004-12-21 Active

More director information

Corporation Filing History
Companies House Filing History
This is a record of the public documents (corporate filing) lodged from Companies House where the company has filed annual returns and other statutory filing documents. Examples of documents filed include: change of registered office, accounts filing, director/officer appointments & resignations, changes in share capital, shareholder members lists etc.

DateDocument TypeDocument Description
2018-10-20GAZ2Final Gazette dissolved via compulsory strike-off
2018-07-20AM23Liquidation. Administration move to dissolve company
2018-07-03AM15Liquidation. Notice of resignation of administrator
2018-07-03AM01Appointment of an administrator
2018-03-15AM10Administrator's progress report
2017-10-05AM06Notice of deemed approval of proposals
2017-10-05AM03Statement of administrator's proposal
2017-09-27AM02Liquidation statement of affairs AM02SOA/AM02SOC
2017-09-12AD01REGISTERED OFFICE CHANGED ON 12/09/17 FROM 45B Western Avenue Milton Park Abingdon Oxfordshire OX14 4RU
2017-09-11AM01NOTICE OF ADMINISTRATOR'S APPOINTMENT:LIQ. CASE NO.1:IP NO.00013790,00008931
2017-09-11AM01NOTICE OF ADMINISTRATOR'S APPOINTMENT:LIQ. CASE NO.1:IP NO.00013790,00008931
2017-04-28AP01DIRECTOR APPOINTED MR JAMES ANTHONY OTTER
2017-03-31AAFULL ACCOUNTS MADE UP TO 30/06/16
2017-03-08CS01CONFIRMATION STATEMENT MADE ON 08/03/17, WITH UPDATES
2017-02-20LATEST SOC20/02/17 STATEMENT OF CAPITAL;GBP 1005.5752
2017-02-20SH0119/01/17 STATEMENT OF CAPITAL GBP 1005.5752
2017-02-13TM01APPOINTMENT TERMINATED, DIRECTOR BRYAN MORTON
2017-02-13TM01APPOINTMENT TERMINATED, DIRECTOR MEDINNOVATE LTD
2017-02-13AP01DIRECTOR APPOINTED MR FRASER ANDREW SKIRROW
2017-02-01MR01REGISTRATION OF A CHARGE / CHARGE CODE 041737890004
2017-01-27CS01CONFIRMATION STATEMENT MADE ON 14/01/17, WITH UPDATES
2017-01-19RES11DISAPPLICATION OF PRE-EMPTION RIGHTS
2017-01-19RES01ADOPT ARTICLES 22/12/2016
2017-01-19RES10Resolutions passed:
  • Resolution of allotment of securities
  • Resolution of removal of pre-emption rights
  • Resolution of adoption of Articles of Association
2016-12-07TM01APPOINTMENT TERMINATED, DIRECTOR MARK CARNEGIE-BROWN
2016-08-12AA01Previous accounting period shortened from 31/12/16 TO 30/06/16
2016-05-19AAFULL ACCOUNTS MADE UP TO 31/12/15
2016-02-12LATEST SOC12/02/16 STATEMENT OF CAPITAL;GBP 980.2802
2016-02-12AR0114/01/16 ANNUAL RETURN FULL LIST
2015-06-01AAFULL ACCOUNTS MADE UP TO 31/12/14
2015-03-18LATEST SOC18/03/15 STATEMENT OF CAPITAL;GBP 980.2802
2015-03-18AR0114/01/15 FULL LIST
2014-07-09AAACCOUNTS FOR 'SMALL' CO. MADE UP TO 31/12/13
2014-07-04AP01DIRECTOR APPOINTED MR RICHARD EDWARD BUNGAY
2014-02-12LATEST SOC12/02/14 STATEMENT OF CAPITAL;GBP 980.28
2014-02-12AR0114/01/14 FULL LIST
2013-11-04AP01DIRECTOR APPOINTED MR BRYAN GEOFFREY MORTON
2013-11-04TM01APPOINTMENT TERMINATED, DIRECTOR CHARLES POTTER
2013-11-04TM01APPOINTMENT TERMINATED, DIRECTOR MARK KIRBY
2013-10-10AUDAUDITOR'S RESIGNATION
2013-08-09AAACCOUNTS FOR 'SMALL' CO. MADE UP TO 31/12/12
2013-05-29AD01REGISTERED OFFICE CHANGED ON 29/05/2013 FROM 45B MILTON PARK ABINGDON OXFORDSHIRE OX14 4RU
2013-05-28AP02CORPORATE DIRECTOR APPOINTED MEDINNOVATE LTD
2013-05-28TM01APPOINTMENT TERMINATED, DIRECTOR FRASER SKIRROW
2013-03-14SH0122/02/13 STATEMENT OF CAPITAL GBP 280.72
2013-03-11TM01APPOINTMENT TERMINATED, DIRECTOR JAMES OTTER
2013-03-06AP01DIRECTOR APPOINTED DR MARK CARNEGIE-BROWN
2013-02-26MG02DECLARATION OF SATISFACTION IN FULL OR IN PART OF A MORTGAGE OR CHARGE /FULL /CHARGE NO 3
2013-02-25RES01ADOPT ARTICLES 18/02/2013
2013-02-25RES12VARYING SHARE RIGHTS AND NAMES
2013-02-06AR0114/01/13 FULL LIST
2012-12-17TM02APPOINTMENT TERMINATED, SECRETARY VANESSA YOUNG
2012-07-04AAACCOUNTS FOR 'SMALL' CO. MADE UP TO 31/12/11
2012-06-21MG02DECLARATION OF SATISFACTION IN FULL OR IN PART OF A MORTGAGE OR CHARGE /FULL /CHARGE NO 1
2012-06-21MG02DECLARATION OF SATISFACTION IN FULL OR IN PART OF A MORTGAGE OR CHARGE /FULL /CHARGE NO 2
2012-06-01MG01PARTICULARS OF A MORTGAGE OR CHARGE / CHARGE NO: 3
2012-05-16SH0116/04/12 STATEMENT OF CAPITAL GBP 476.49
2012-02-07SH0119/01/12 STATEMENT OF CAPITAL GBP 476.1056
2012-02-03AR0114/01/12 FULL LIST
2012-02-03CH01DIRECTOR'S CHANGE OF PARTICULARS / MR JAMES ANTHONY OTTER / 03/02/2012
2012-01-09AP01DIRECTOR APPOINTED DR IAN JOSEPH SMITH
2011-12-06SH0131/10/11 STATEMENT OF CAPITAL GBP 474.79
2011-06-09RES01ALTER ARTICLES 27/05/2011
2011-06-09RES10AUTHORISED ALLOTMENT OF SHARES AND DEBENTURES
2011-05-18AP01DIRECTOR APPOINTED MR JAMES ANTHONY OTTER
2011-04-27TM02APPOINTMENT TERMINATED, SECRETARY SIMON JONES
2011-04-27AP03SECRETARY APPOINTED MISS VANESSA JANE YOUNG
2011-04-01AAACCOUNTS FOR 'SMALL' CO. MADE UP TO 31/12/10
2011-02-25AA01PREVSHO FROM 31/03/2011 TO 31/12/2010
2011-02-15AR0114/01/11 FULL LIST
2011-02-15CH03SECRETARY'S CHANGE OF PARTICULARS / MR SIMON JONES / 01/02/2010
2010-10-19TM01APPOINTMENT TERMINATED, DIRECTOR RUSSELL SMITH
2010-10-13TM01APPOINTMENT TERMINATED, DIRECTOR CHARLES SWINGLAND
2010-10-13TM01APPOINTMENT TERMINATED, DIRECTOR SIMON JONES
2010-07-19AAACCOUNTS FOR 'SMALL' CO. MADE UP TO 31/03/10
2010-04-21RES01ALTER ARTICLES 10/03/2010
2010-04-16MEM/ARTSARTICLES OF ASSOCIATION
2010-04-14SH0116/03/10 STATEMENT OF CAPITAL GBP 460.64
2010-02-16SH0103/02/10 STATEMENT OF CAPITAL GBP 460.04
2010-02-11AR0114/01/10 FULL LIST
2010-01-28SH0117/12/09 STATEMENT OF CAPITAL GBP 436.10
2010-01-28SH0124/12/09 STATEMENT OF CAPITAL GBP 437.8924
2010-01-25AR0131/12/09 FULL LIST
2010-01-25CH01DIRECTOR'S CHANGE OF PARTICULARS / FRASER ANDREW SKIRROW / 31/12/2009
2010-01-25CH01DIRECTOR'S CHANGE OF PARTICULARS / CHARLES DAVID OGILVY POTTER / 31/12/2009
2010-01-25CH01DIRECTOR'S CHANGE OF PARTICULARS / MARK RICHARD KIRBY / 31/12/2009
2010-01-25CH01DIRECTOR'S CHANGE OF PARTICULARS / SIMON JONES / 31/12/2009
2009-11-19SH0129/09/09 STATEMENT OF CAPITAL GBP 25.662672
2009-11-19SH0128/09/09 STATEMENT OF CAPITAL GBP 19.1809
2009-08-10MEM/ARTSARTICLES OF ASSOCIATION
2009-08-10RES01ALTER ARTICLES 05/08/2009
2009-06-10AAACCOUNTS FOR 'SMALL' CO. MADE UP TO 31/03/09
2009-06-08RES01ADOPT ARTICLES 26/03/2009
2009-01-27363aRETURN MADE UP TO 31/12/08; FULL LIST OF MEMBERS
2008-12-30AUDAUDITOR'S RESIGNATION
2008-09-04363(190)LOCATION OF DEBENTURE REGISTER ADDRESS CHANGED
2008-09-04363sRETURN MADE UP TO 31/12/07; FULL LIST OF MEMBERS
2008-07-03AAACCOUNTS FOR 'SMALL' CO. MADE UP TO 31/03/08
2008-03-11288cDIRECTOR'S CHANGE OF PARTICULARS / CHARLES SWINGLAND / 15/02/2008
2007-11-05AAACCOUNTS FOR 'SMALL' CO. MADE UP TO 31/03/07
2007-09-07123NC INC ALREADY ADJUSTED 08/08/07
2007-09-07RES04£ NC 500/550
2007-09-07RES01ALTERATION TO MEMORANDUM AND ARTICLES
2007-05-04395PARTICULARS OF MORTGAGE/CHARGE
2007-02-23363(190)LOCATION OF DEBENTURE REGISTER ADDRESS CHANGED
2007-02-23363sRETURN MADE UP TO 31/12/06; FULL LIST OF MEMBERS
Industry Information
SIC/NAIC Codes
72 - Scientific research and development
721 - Research and experimental development on natural sciences and engineering
72190 - Other research and experimental development on natural sciences and engineering




Licences & Regulatory approval
We could not find any licences issued to GLIDE PHARMACEUTICAL TECHNOLOGIES LIMITED or authorisation from an industry specific regulator to operate. These may not be required.
Share this page on Facebook
Risks
Legal Notices
Notice of 2017-11-23
Appointmen2017-09-05
Fines / Sanctions
No fines or sanctions have been issued against GLIDE PHARMACEUTICAL TECHNOLOGIES LIMITED
Liabilities
Mortgages / Charges
Total # Mortgages/Charges 4
Mortgages/Charges outstanding 1
Mortgages Partially Satisifed 0
Mortgages Satisfied/Paid 3
Details of Mortgagee Charges
Charge Type Date of Charge Charge Status Mortgagee
DEBENTURE 2012-05-31 Satisfied PHILIP BASIL (THE "SECURITY TRUSTEE")
CHARGE 2007-05-01 Satisfied BARCLAYS MERCANTILE BUSINESS FINANCE LIMITED
DEBENTURE 2006-05-24 Satisfied BARCLAYS BANK PLC
Filed Financial Reports
Annual Accounts
2014-12-31
Annual Accounts
2013-12-31
Annual Accounts
2012-12-31
Annual Accounts
2011-12-31

These are the financial reports (either an abhreviated set of accounts or profit& loss statement and balance sheet) have been filed with Companies House. The reports allow you to do a basic business credit check on GLIDE PHARMACEUTICAL TECHNOLOGIES LIMITED

Intangible Assets
Patents

Intellectual Property Patents Registered by GLIDE PHARMACEUTICAL TECHNOLOGIES LIMITED

GLIDE PHARMACEUTICAL TECHNOLOGIES LIMITED has registered 2 patents

GB2446943 , GB2446780 ,

Domain Names

GLIDE PHARMACEUTICAL TECHNOLOGIES LIMITED owns 3 domain names.

caretekmedical.co.uk   glidepharma.co.uk   sumaglide.co.uk  

Trademarks

Trademark applications by GLIDE PHARMACEUTICAL TECHNOLOGIES LIMITED

GLIDE PHARMACEUTICAL TECHNOLOGIES LIMITED is the Original Applicant for the trademark GLIDE TECHNOLOGIES ™ (86719803) through the USPTO on the 2015-08-10
Pharmaceutical, veterinary and agricultural preparations and substances; pharmaceutical, veterinary and agricultural preparations and substances for the diagnosis of, treatment of or protection against infectious diseases, pain, inflammation, sepsis, alopecia and obesity; pharmaceutical, veterinary and agricultural preparations and substances for the diagnosis of, treatment of or protection against viral, metabolic, musculoskeletal, cardiovascular, genitourinary, central nervous system, endocrinological, immunological, obstetrical, gynaecological, oncological, respiratory, neurological, gastrointestinal, hormonal, dermatological and psychiatric related diseases and disorders; pharmaceutical, veterinary and agricultural preparations and substances for skin and tissue repair; prophylactic pharmaceutical, veterinary and agricultural preparations and substances; vaccines, prophylactic vaccines, therapeutic vaccines; contraceptive preparations and substances; assays and reagents for diagnostic purposes; assays and reagents for use in cancer diagnosis
Income
Government Income
We have not found government income sources for GLIDE PHARMACEUTICAL TECHNOLOGIES LIMITED. This could be because the transaction value was below £ 500 with local government or below £ 25,000 for central government. We have found 8,000 supplier to government that are UK companies so approx 0.2% of companies listed on Datalog supply to government.

The top companies supplying to UK government with the same SIC code (72190 - Other research and experimental development on natural sciences and engineering) as GLIDE PHARMACEUTICAL TECHNOLOGIES LIMITED are:

OAKLEA LTD. £ 237,880
TRL LIMITED £ 130,521
SGS MIS ENVIRONMENTAL LTD £ 18,077
BUILDING RESEARCH ESTABLISHMENT LIMITED £ 13,354
WILDKNOWLEDGE LTD £ 8,604
FONTENERGY LTD £ 4,300
T-CUBED LTD £ 2,599
MARWELL WILDLIFE £ 1,089
CAMPDEN BRI (CHIPPING CAMPDEN) LIMITED £ 1,000
SITE ANALYTICAL SERVICES LIMITED £ 950
DNAE GROUP HOLDINGS LIMITED £ 8,493,738
TRL LIMITED £ 1,750,794
BUILDING RESEARCH ESTABLISHMENT LIMITED £ 1,586,573
MAGNOMATICS LIMITED £ 1,000,000
GILL RESEARCH & DEVELOPMENT LIMITED £ 996,786
EARLHAM INSTITUTE £ 750,000
CRAWLEY CREATURES LIMITED £ 561,896
SHEFFIELD HALLAM UNIVERSITY ENTERPRISES LTD £ 561,104
SITE ANALYTICAL SERVICES LIMITED £ 522,264
ALGAECYTES LIMITED £ 520,000
DNAE GROUP HOLDINGS LIMITED £ 8,493,738
TRL LIMITED £ 1,750,794
BUILDING RESEARCH ESTABLISHMENT LIMITED £ 1,586,573
MAGNOMATICS LIMITED £ 1,000,000
GILL RESEARCH & DEVELOPMENT LIMITED £ 996,786
EARLHAM INSTITUTE £ 750,000
CRAWLEY CREATURES LIMITED £ 561,896
SHEFFIELD HALLAM UNIVERSITY ENTERPRISES LTD £ 561,104
SITE ANALYTICAL SERVICES LIMITED £ 522,264
ALGAECYTES LIMITED £ 520,000
DNAE GROUP HOLDINGS LIMITED £ 8,493,738
TRL LIMITED £ 1,750,794
BUILDING RESEARCH ESTABLISHMENT LIMITED £ 1,586,573
MAGNOMATICS LIMITED £ 1,000,000
GILL RESEARCH & DEVELOPMENT LIMITED £ 996,786
EARLHAM INSTITUTE £ 750,000
CRAWLEY CREATURES LIMITED £ 561,896
SHEFFIELD HALLAM UNIVERSITY ENTERPRISES LTD £ 561,104
SITE ANALYTICAL SERVICES LIMITED £ 522,264
ALGAECYTES LIMITED £ 520,000
Outgoings
Business Rates/Property Tax
No properties were found where GLIDE PHARMACEUTICAL TECHNOLOGIES LIMITED is liable for the business rates / property tax. This could be for a number of reasons.
  • The council hasnt published the data
  • We havent found or been able to process the councils data
  • The company is part of a group of companies and another company in the group is liable for business rates
  • The registered office may be a residential address which does not have a commercial designation. If the business is run from home then it won't be a commercial property and hence won't be liable for business rates.
  • Serviced offices are increasingly popular and therefore a business may not be paying business rates directly - the building owner is and this is incorporated in the office rental charge.
Import/Export of Goods
Goods imported/exported by GLIDE PHARMACEUTICAL TECHNOLOGIES LIMITED
OriginDestinationDateImport CodeImported Goods classification description
2016-04-0084798997Machines, apparatus and mechanical appliances, n.e.s.
2016-02-0084798997Machines, apparatus and mechanical appliances, n.e.s.
2015-12-0084798997Machines, apparatus and mechanical appliances, n.e.s.
2015-07-0129372900Steroidal hormones, their derivatives and structural analogues, used primarily as hormones (excl. cortisone, hydrocortisone, prednisone "dehydrocortisone", prednisolone "dehydrohydrocortisone", halogenated derivatives of corticosteroidal hormones, oestrogens and progestogens)
2015-07-0029372900Steroidal hormones, their derivatives and structural analogues, used primarily as hormones (excl. cortisone, hydrocortisone, prednisone "dehydrocortisone", prednisolone "dehydrohydrocortisone", halogenated derivatives of corticosteroidal hormones, oestrogens and progestogens)
2015-02-0129371900Polypeptide hormones, protein hormones and glycoprotein hormones, their derivatives and structural analogues, used primarily as hormones (excl. somatropin, its derivatives and structural analogues, and insulin and its salts)
2015-02-0029371900Polypeptide hormones, protein hormones and glycoprotein hormones, their derivatives and structural analogues, used primarily as hormones (excl. somatropin, its derivatives and structural analogues, and insulin and its salts)
2015-01-0129371900Polypeptide hormones, protein hormones and glycoprotein hormones, their derivatives and structural analogues, used primarily as hormones (excl. somatropin, its derivatives and structural analogues, and insulin and its salts)
2015-01-0029371900Polypeptide hormones, protein hormones and glycoprotein hormones, their derivatives and structural analogues, used primarily as hormones (excl. somatropin, its derivatives and structural analogues, and insulin and its salts)
2014-11-0129371900Polypeptide hormones, protein hormones and glycoprotein hormones, their derivatives and structural analogues, used primarily as hormones (excl. somatropin, its derivatives and structural analogues, and insulin and its salts)
2014-10-0129371900Polypeptide hormones, protein hormones and glycoprotein hormones, their derivatives and structural analogues, used primarily as hormones (excl. somatropin, its derivatives and structural analogues, and insulin and its salts)
2014-08-0129371900Polypeptide hormones, protein hormones and glycoprotein hormones, their derivatives and structural analogues, used primarily as hormones (excl. somatropin, its derivatives and structural analogues, and insulin and its salts)
2014-04-0129371900Polypeptide hormones, protein hormones and glycoprotein hormones, their derivatives and structural analogues, used primarily as hormones (excl. somatropin, its derivatives and structural analogues, and insulin and its salts)
2014-03-0129371900Polypeptide hormones, protein hormones and glycoprotein hormones, their derivatives and structural analogues, used primarily as hormones (excl. somatropin, its derivatives and structural analogues, and insulin and its salts)
2014-03-0138220000Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2014-01-0129371900Polypeptide hormones, protein hormones and glycoprotein hormones, their derivatives and structural analogues, used primarily as hormones (excl. somatropin, its derivatives and structural analogues, and insulin and its salts)
2013-12-0129371900Polypeptide hormones, protein hormones and glycoprotein hormones, their derivatives and structural analogues, used primarily as hormones (excl. somatropin, its derivatives and structural analogues, and insulin and its salts)
2013-12-0173181590Screws and bolts, of iron or steel "whether or not with their nuts and washers", with heads (excl. slotted and cross-recessed screws and bolts, hexagon head screws and bolts; wood screws, self-tapping screws and screws and bolts for fixing railway track construction material, screw hooks, screw rings and lag screws)
2013-09-0129371900Polypeptide hormones, protein hormones and glycoprotein hormones, their derivatives and structural analogues, used primarily as hormones (excl. somatropin, its derivatives and structural analogues, and insulin and its salts)
2013-08-0129371900Polypeptide hormones, protein hormones and glycoprotein hormones, their derivatives and structural analogues, used primarily as hormones (excl. somatropin, its derivatives and structural analogues, and insulin and its salts)
2013-06-0184433990Printers and facsimile machines (excl. those capable of connecting to an automatic data processing machine or to a network)
2013-05-0129371900Polypeptide hormones, protein hormones and glycoprotein hormones, their derivatives and structural analogues, used primarily as hormones (excl. somatropin, its derivatives and structural analogues, and insulin and its salts)
2013-01-0184798930Mobile hydraulic powered mine roof supports
2012-03-0129371900Polypeptide hormones, protein hormones and glycoprotein hormones, their derivatives and structural analogues, used primarily as hormones (excl. somatropin, its derivatives and structural analogues, and insulin and its salts)
2011-12-0184799080Parts of machines and mechanical appliances having individual functions, n.e.s. (excl. of cast iron or cast steel)
2011-02-0190189084Instruments and appliances used in medical, surgical or veterinary sciences, n.e.s.
2010-12-0184799080Parts of machines and mechanical appliances having individual functions, n.e.s. (excl. of cast iron or cast steel)
2010-12-0190279050Parts and accessories of instruments and apparatus for physical or chemical analysis, e.g. polarimeters, refractometers, spectrometers, of instruments and apparatus for measuring or checking viscosity, porosity, expansion, surface tension or the like and of instruments and apparatus for measuring or checking quantities of heat, sound or light, incl. exposure meters, n.e.s. (excl. of gas or smoke analysis apparatus)
2010-11-0184799080Parts of machines and mechanical appliances having individual functions, n.e.s. (excl. of cast iron or cast steel)

For goods imported into the United Kingdom, only imports originating from outside the EU are shown

Legal Notices/Action
Initiating party Event TypeNotice of
Defending partyGLIDE PHARMACEUTICAL TECHNOLOGIES LIMITEDEvent Date2017-11-23
 
Government Grants / Awards
Technology Strategy Board Awards
GLIDE PHARMACEUTICAL TECHNOLOGIES LIMITED has been awarded 3 awards from the Technology Strategy Board. The value of these awards is £ 2,687,895

CategoryAward Date Award/Grant
Room temperature stable solid vaccine formulations suitable for needle free delivery : Feasibility Study 2013-06-01 £ 150,000
Novel Teriparatide (PTH) Formulation : Feasibility Study 2013-04-01 £ 2,287,895
Novel epinephrine formulations : Smart - Development of Prototype 2012-06-01 £ 250,000

How is this useful? The company may be investing in new products to generate new revenue streams or investing in new technologies to increase productivity / reduce costs. The company may own IPR as a result.

European Union CORDIS Awards
The European Union has not awarded GLIDE PHARMACEUTICAL TECHNOLOGIES LIMITED any grants or awards.
Ownership
    We could not find any group structure information
    Is this data useful to you?
    If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. Please DONATE to help.
    Alternatively by linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us.
    Need more information?
    We offer bespoke investigations into companies. If you need more information about this company we can gather more information as directed by you. This may, for example, be a forensic investigation such as tracing hidden assets. The engagement is on a time and materials basis. We charge GBP £ 500 per day + VAT. Contact us with a description of what you're looking for and we will assess whether we can help.